Last reviewed · How we verify
Philadelphia Chromosome Positive Chronic Myelocytic Leukemia
Approved treatments
- Gleevec · M.D. Anderson Cancer Center
- Sprycel · Handa Therap
Sprycel works by blocking the activity of a specific protein called Ephrin type-B receptor 6, which is involved in the growth and survival of cancer cells. - Busilvex · medac GmbH
- Gleevec · Novartis
Gleevec works by blocking the activity of specific enzymes involved in cancer cell growth and proliferation. - Busulfex · Waylis
Busulfex works by attaching an alkyl group to the DNA of cancer cells, interfering with their ability to replicate and ultimately leading to cell death. - Tasigna · Cipla
Tasigna works by blocking the abnormal Bcr/Abl protein that drives the growth of cancer cells in CML. - busulfex · Dana-Farber Cancer Institute
- Busulphan · University of Birmingham
- Tasigna · XSpray Microparticles
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Philadelphia Chromosome Positive Chronic Myelocytic Leukemia patent landscape — cliff calendar, originator estates, attackable patents
- Philadelphia Chromosome Positive Chronic Myelocytic Leukemia treatment landscape brief
- Philadelphia Chromosome Positive Chronic Myelocytic Leukemia treatment updates RSS
Frequently asked questions about Philadelphia Chromosome Positive Chronic Myelocytic Leukemia
What drugs treat Philadelphia Chromosome Positive Chronic Myelocytic Leukemia?
Tracked treatments include Gleevec, Sprycel, Busilvex, Busulfex, Tasigna, busulfex, Busulphan.
What is the treatment for Philadelphia Chromosome Positive Chronic Myelocytic Leukemia?
Standard treatment for Philadelphia Chromosome Positive Chronic Myelocytic Leukemia includes Gleevec, Sprycel, Busilvex, Busulfex, Tasigna. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Philadelphia Chromosome Positive Chronic Myelocytic Leukemia patent cliff · Philadelphia Chromosome Positive Chronic Myelocytic Leukemia CI report
- Treatment: Gleevec · M.D. Anderson Cancer Center
- Treatment: Sprycel · Handa Therap
- Treatment: Busilvex · medac GmbH
- Treatment: Gleevec · Novartis
- Treatment: Busulfex · Waylis
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing